Rootman, Joseph M.
Kryskow, Pamela
Harvey, Kalin
Stamets, Paul
Santos-Brault, Eesmyal
Kuypers, Kim P. C.
Polito, Vince
Bourzat, Francoise
Walsh, Zach
Article History
Received: 20 February 2021
Accepted: 28 October 2021
First Online: 18 November 2021
Competing interests
: Joseph Rootman has received research funding from Quantified Citizen Technologies who provided the data collection platform for this study. Pamela Kryskow is a member of the clinical advisory board of Numinus Wellness which is a company that provides psychedelic psychotherapy services. Pamela Kryskow is compensated for this role with Numinus stock. Kalin Harvey is the CTO and co-founder of Quantified Citizen which is a company that produces software for decentralized mobile research, which was used in this study. Paul Stamets is a minority investor in Quantified Citizen and is an applicant on pending patents combining psilocybin mushrooms, Lions Mane mushrooms and niacin. Eesmyal Santos-Brault is the CEO and co-founder of Quantified Citizen which is a company that produces software for decentralized mobile research, which was used in this study. Kim PC Kuypers is a principle investigator on research projects, the present study not included, that are sponsored by Mindmed and Silopharma which are companies that are developing psychedelic medicines. Vince Polito is a science advisor for Mydecine Innovations Group, which is a company that is developing psychedelic medicines. Francoise Bourzat is a collaborator in the study on psilocybin assisted psychotherapy for COVID related grief at Pacific Neuroscience Institute, Santa Monica, CA. Zach Walsh is in paid advisory relationships with Numinus Wellness and Entheo Tech Biomedical regarding the medical development of psychedelics.